Why the study?
Anthracyclines increase the risk of dose-dependent cardiotoxicity, and the benefits of exercise in anthracycline-mediated cardiotoxicity are not clearly understood.
Does exercise reduce anthracycline-mediated cardiovascular complications in females with breast cancer?
Population
Females with breast cancer who received anthracycline-based chemotherapy, and pre-clinical models
Comparison
Aerobic and resistance exercise
Design
Review
Authors
Loading...
Exercise may attenuate anthracycline cardiotoxicity in breast cancer survivors; leaves open optimal prescription, timing, and long-term cardiac outcomes.
Does exercise reduce anthracycline-mediated cardiovascular complications in females with breast cancer?
Exercise is a promising intervention for reducing anthracycline-mediated cardiotoxicity in breast cancer survivors, though specific exercise prescriptions require further clinical trials.
Varghese et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: